Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Immunogenicity and safety study in preterm and full-term infants of GSK Biologicals' Hib-menC vaccine, Menitorix co-administered with Infanrix Penta and Prevenar at 2, 4, 6 months and as a booster with Infanrix IPV and Prevenar at 16-18 months.

Next Previous
X
Search
Trial Profile

Immunogenicity and safety study in preterm and full-term infants of GSK Biologicals' Hib-menC vaccine, Menitorix co-administered with Infanrix Penta and Prevenar at 2, 4, 6 months and as a booster with Infanrix IPV and Prevenar at 16-18 months.

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 05 Sep 2023

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Hib-meningococcal vaccine group C conjugate (Primary) ; DTaP poliovirus vaccine; DTaP-hepatitis B-poliovirus vaccine; Pneumococcal 7-valent CRM197 vaccine conjugate
  • Indications Diphtheria; Haemophilus infections; Hepatitis B; Meningococcal infections; Pertussis; Pneumococcal infections; Poliomyelitis; Tetanus
  • Focus Pharmacodynamics; Pharmacokinetics; Registrational
  • Acronyms Hib-MenC-TT-032 PRI & BST
  • Sponsors GlaxoSmithKline; GSK

    • Most Recent Events

    • 19 Feb 2010 Actual end date (1 Nov 2009) added as reported by ClinicalTrials.gv record.
    • 19 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 27 Jan 2010 Planned number of patients changed from 300 to 313 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top